Skip to main content
. 2021 Aug 12;8(5):3906–3916. doi: 10.1002/ehf2.13368

Table 3.

Treatment episodes

Inpatients (n) HeartFailure@Home
All Day unit Home IV
Number of patients (n) 75 79 a 52 33
Number of episodes (n, %) 89 114 78 36
Median duration of IV diuretic treatment (days, range) 7, range 1–43 (data for 84 episodes) 6 (range 0–36, data for 98) 6, range 0–36, (data for 70 episodes) 7, range 1–14 (data for 28 episodes)
Concomitant thiazide prescription (%) 27 (36.0%) 12 (14.1%) 10 (19.2%) 2 (6.1%)
Mean weight loss (kg, range) −4.9 kg (−26.6 kg to +4.0 kg) (data for 77 episodes) −3.1 kg (−8.9 to 1.2 kg) (data for 60 episodes) −3.1 kg (−3.8 to +1.2 kg) (data for 44 episodes) −3.1 kg (−8.2 to + 0.6) (data for 16 episodes)
Episode outcomes
Uncomplicated episodes (n, %) 69 (82.1%, data for 84 episodes) 74 (84.1%, data for 88 episodes) 52 (81.3%, data for 64 episodes) 22 (91.7%, data for 24 episodes)
Complicated episodes b (n, %)
Hospitalization NA 13 (11.4%) 11 c (14.1%) 2 d (5.6%)
AKI 7 (8.3%, data for 84 episodes) 1 (1.2%, data for 87 episodes) 1 (1.6%, data for 63 episodes) 0 (data for 24 episodes)
Died during episode 12 (13.5%) (five expected and seven unexpected) 2 (2%) 1 (1.3%) (expected) 1 (2.8%) (expected)

Data available for all episodes unless otherwise stated.

a

Six patients used both home IV and day unit for different episodes.

b

Some patients experienced more than 1 complication (e.g. hospitalized and then died)

c

Ten for higher dose diuretics and one due to transport issues.

d

Hyponatraemia, higher dose diuretics.